
    Original Text: Currently participating and receiving study therapy or has participated in a study of an investigational agent and received study therapy or used an investigational device within 4 weeks of the first dose of study treatment
    Disease/Condition: none
    Procedure: None
    Drug: None
    Biomarker: None
    Computable Rule: "Currently participating and receiving study therapy" OR "has participated in a study of an investigational agent and received study therapy" OR "used an investigational device" is True

Criterion:
    Patients with histologically confirmed advanced solid tumors, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), breast cancer, colorectal cancer, gastric cancer, pancreatic cancer, hepatocellular carcinoma, cholangiocarcinoma, esophageal cancer, gallbladder cancer, biliary tract cancer, renal cell carcinoma, urothelial carcinoma, ovarian cancer, cervical cancer, endometrial cancer, prostate cancer, bladder cancer, head